Table 4.
African- Americans (n=679) | European-American (n=692) | |||||
---|---|---|---|---|---|---|
No. of controls* |
No. | OR (CI) | No. of controls |
No. | OR (CI) | |
Menopause | ||||||
Yes | 244 | 110 | 1.45 (1.03, 2.04) | 359 | 148 | 2.13 (1.38, 3.29) |
No | 248 | 77 | 1.00 | 155 | 30 | 1.00 |
Diabetes | ||||||
Yes | 113 | 57 | 1.47 (1.01, 2.14) | 63 | 10 | 0.43 (0.21, 0.85) |
No | 379 | 130 | 1.00 | 451 | 168 | 1.00 |
Diabetes Medication |
||||||
Yes | 96 | 48 | 1.43 (0.96, 2.12) | 53 | 6 | 0.30 (0.13, 0.72) |
No | 396 | 139 | 1.00 | 461 | 172 | 1.00 |
Breast Cancer | ||||||
Stage III | 8 | 38 | 53.4 (18.7, 152.8) | 8 | 35 | 31.6 (11.2, 89.1) |
Stage II | 155 | 88 | 6.39 (2.96, 13.8) | 138 | 55 | 2.88 (1.34, 6.18) |
Stage I | 239 | 53 | 2.50 (1.14, 5.45) | 303 | 79 | 1.88 (0.90, 3.95) |
Stage 0** | 90 | 8 | 1.00 | 65 | 9 | 1.00 |
Controls refer to individuals who are alive
In situ, localized